VARC-2 30-day clinical outcomes
| Overall | CoreValve | Evolut R | P values | |
| (n=113) | (n=60) | (n=53) | ||
| All-cause mortality | ||||
| 30 days | 7 (6) | 5 (8) | 2 (4) | 0.4 |
| 6 months | 9 (8) | 7 (12) | 2 (4) | 0.2 |
| Cardiovascular mortality | ||||
| 30 days | 3 (3) | 2 (3) | 1 (2) | 0.6 |
| 6 months | 5 (4) | 4 (7) | 1 (2) | 0.2 |
| All strokes | 7 (6) | 4 (7) | 3 (6) | 1 |
| Disabling, % of strokes | 4 (57) | 3 (75) | 1 (33) | |
| Life-threatening bleeding | 5 (4) | 2 (3) | 3 (6) | 0.7 |
| Major vascular complications | 6 (5) | 2 (3) | 4 (7) | 0.4 |
| AKIN 2 or 3 | 6 (5) | 4 (7) | 2 (4) | 0.7 |
Values are number (%). AKIN, acute kidney injury network; VARC, valve academic research consortium.